Arun P. Wiita MD PhD
Molecular Genetics, Anatomic Pathology, Clinical Pathology
Assistant Professor, Dept. of Laboratory Medicine
Join to view full profile
185 Berry StChina Basin UCSF Lab Medicine Box 0506San Francisco, CA 94107
Phone+1 415-353-1469
Dr. Wiita is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 2009 - 2012
Columbia University Vagelos College of Physicians and SurgeonsClass of 2009
Columbia UniversityPhD, Neurobiology/Biophysics, With Distinction, 2004 - 2008
Princeton UniversityAB, Chemistry, Magna Cum Laude, 1998 - 2002
Certifications & Licensure
CA State Medical License 2010 - 2026
American Board of Pathology Pathology - Clinical
Awards, Honors, & Recognition
- Dale Frey Breakthrough Award Damon Runyon Cancer Research Foundation, 2015
- K08 Mentored Clinical Scientist Award NIH-National Cancer Institute, 2014
- Post-Doctoral Fellowship Award Damon Runyon Cancer Research Foundation, 2012
Publications & Presentations
PubMed
- Extending structural surfaceomics to identify aberrant conformations of tumor surface proteins as potential immunotherapy targets.Audrey Kishishita, Sabine Cismoski, Tianna Grant, Rucha Deo, Sanjana Prudhvi
Biorxiv. 2026-05-18 - Multivalent recognition of ferritin by full-length NCOA4 enables robust ferritinophagy.Ayush K Srivastava, Genki Terashi, Rosa Viner, Audrey Kishishita, Arun P Wiita
Protein Science. 2026-05-01 - 1 citationsSynergistic Treatment of Prostate Cancer and Multiple Myeloma using CD46-Targeted Radioimmunotherapy Antibody-Drug Conjugates.Anil P Bidkar, Scott Bidlingmaier, Anju Wadhwa, Ellis Mayne, Athira Raveendran
Clinical Cancer Research. 2026-04-15
Abstracts/Posters
- Ifitm3 Is Essential for PI(3,4,5)P3-Dependent B-Cell Activation and LeukemogenesisArun P. Wiita, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- In Vitro-Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell MalignanciesArun P. Wiita, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and _Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and BiologyArun P. Wiita, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
ADLM 2026 Draws 17,000 Attendees to Explore Advances in Clinical Laboratory MedicineJuly 30th, 2026- Hutch Scientists Receive $25M to Solve Breast Cancer MetastasisJuly 27th, 2022
- Research Round-up: Multiple MyelomaNovember 25th, 2020
Grant Support
- Selective treatment of acute myeloid leukemia with radioimmunotherapies targeting the active conformation of integrin beta-2UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2025–2030
- Structural surfaceomics to probe conformation-selective immunotherapy targetsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
- Development of CD46 theranostics for imaging and treatment of multiple myelomaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: